Milestone Reached for SGLT2 Inhibitor Aimed at Heart Attack Population

(MedPage Today) -- BARCELONA--Starting patients on empagliflozin (Jardiance) in the acute phase of a large myocardial infarction (MI) resulted in improvements in surrogate markers of heart failure (HF) and heart function over the next half...